Article

Modifiable Risk Factors Increase Total Joint Replacement Risk

Being overweight and reporting vigorous physical activity increase the risk of undergoing total joint replacement (TJR); severe osteoarthritis (OA) is the most common indicator for this procedure.

 

Being overweight and reporting vigorous physical activity increase the risk of undergoing total joint replacement (TJR); severe osteoarthritis (OA) is the most common indicator for this procedure. There is a strong inverse dose-response relationship between duration of cigarette smoking and risk of TJR.

Mnatzaganian and associates conducted a cohort study of 11,388 men who had undergone ultrasonographic screening for abdominal aortic aneurysm. Clinical data were integrated with hospital morbidity data and mortality records. Time to TJR was modeled on weight, height, socioeconomic status, comorbidity, vigorous or nonvigorous exercise, and years of smoking. The cohort was divided into 3 age-groups.

Being overweight was significantly associated with TJR, and smoking was inversely associated, showing dose-response relationships across quintiles of the distribution of weight and years of smoking, respectively, in all 3 age-groups. TJR was 42% to 51% less likely to occur in the men who had smoked for 48 years or more than in those who had never smoked. There was a positive association between vigorous exercise and TJR.

The authors noted that more research is needed to better understand the role of smoking in the pathogenesis of OA and the criteria that are used to determine whether patients should undergo TJR.

Comments about/problems with this article? Please send feedback.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.